Clinical trial
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
NCT00207064 · Birte Glenthoj, Other · Completed
Key facts
| NCT number | NCT00207064 |
|---|---|
| Title | Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia |
| Official title | 5-HT2A-receptor Binding: Implications for the Pathophysiology of Schizophrenia and Effects of Treatment With Antipsychotic Drugs |
| Lead sponsor | Birte Glenthoj, Other |
| Collaborators | Rigshospitalet, Denmark Copenhagen University Hospital, Hvidovre Glostrup University Hospital, Copenhagen The Danish Medical Research Council Copenhagen Hospital Corporation University of Copenhagen… |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | quetiapine |
| Enrollment | 46 |
| Start date | Apr 1, 2004 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 19, 2011 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: